Bendamustine Injection 100mg Zumustin

Bendamustine injection 100mg (Zumastin) is a chemotherapy medicine used to treat certain types of cancer, including chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL) that have not responded to other treatments. It belongs to a class of drugs known as alkylating agents, which work by damaging the DNA of cancer cells to stop them from growing and dividing.

• Active Ingredient: Bendamustine Hydrochloride
• Strength: 100mg per vial
• Brand Name: Zumustin
• Form: Injectable solution, administered intravenously

Bendamustine exerts its anti-cancer effect by cross-linking DNA strands, which interferes with the replication of cancer cells and triggers apoptosis (programmed cell death). This makes it effective against rapidly dividing cancer cells.

• Chronic Lymphocytic Leukemia (CLL): It is used in patients who are newly diagnosed or whose disease has progressed.
• Non-Hodgkin’s Lymphoma (NHL): Particularly for patients with inactive B-cell type disease who have relapsed following standard treatment.

Bendamustine is usually administered intravenously over a set number of days in cycles, with a rest period between cycles. The dose and schedule depend on the type of cancer, the condition of the patient, and their response to treatment

Common side effects include:

• Fatigue
• Nausea and vomiting
• Fever and infections due to low white blood cell counts (neutropenia)
• Skin rash
• Anemia
• Diarrhea
• Mouth sores

Bendamustine Injection 100mg Zumustine is an effective cancer treatment, especially for CLL and NHL. As an alkylating agent, it disrupts cancer cell DNA. Due to potential side effects, close monitoring and professional consultation are necessary during treatment.

Check out this Anti Cancer product Benzz 100mg Injection or you may explore more Anti Cancer products by clicking here 

We are an exporter from India and work in many countries, such as the UAE, Oman, Qatar, Myanmar, Saudi Arabia, the Netherlands, Albania, Saint Lucia, Jordan, Romania, and South Africa.